GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (MEX:CRL) » Definitions » Current Deferred Revenue

Charles River Laboratories International (MEX:CRL) Current Deferred Revenue : MXN4,255 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Charles River Laboratories International Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Charles River Laboratories International's current deferred revenue for the quarter that ended in Mar. 2024 was MXN4,255 Mil.

Charles River Laboratories International Current Deferred Revenue Historical Data

The historical data trend for Charles River Laboratories International's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charles River Laboratories International Current Deferred Revenue Chart

Charles River Laboratories International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,864.13 4,976.70 4,506.99 5,151.99 4,104.71

Charles River Laboratories International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,409.47 5,740.09 5,579.83 4,104.71 4,255.00

Charles River Laboratories International Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Charles River Laboratories International (MEX:CRL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (MEX:CRL) » Definitions » Current Deferred Revenue
Comparable Companies
MEDP QGEN EXAS NTRA RVTY DGX LH ILMN RDNT SHC TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT SHSE:603259
Traded in Other Exchanges
CRL:USA RV6:Germany RV6:Germany
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Website
https://www.criver.com
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.